$60,000 of EXELON CORPORATION lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Climate, Energy Related Issues and Tax"
You can find more data on corporate lobbying on Quiver Quantitative.
EXC Congressional Stock Trading
Members of Congress have traded $EXC stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $EXC stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $15,000 on 10/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
EXC Hedge Fund Activity
We have seen 605 institutional investors add shares of EXC stock to their portfolio, and 474 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 35,790,315 shares (-72.1%) from their portfolio in Q4 2025, for an estimated $1,560,099,830
- CAPITAL INTERNATIONAL INVESTORS added 16,938,125 shares (+inf%) to their portfolio in Q4 2025, for an estimated $738,332,868
- CAPITAL WORLD INVESTORS added 8,987,453 shares (+807.4%) to their portfolio in Q4 2025, for an estimated $391,763,076
- BLACKROCK, INC. added 6,218,983 shares (+5.5%) to their portfolio in Q4 2025, for an estimated $271,085,468
- PICTET ASSET MANAGEMENT HOLDING SA removed 5,113,037 shares (-71.7%) from their portfolio in Q4 2025, for an estimated $222,877,282
- ATLAS INFRASTRUCTURE PARTNERS (UK) LTD. removed 4,967,487 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $216,532,758
- BANK OF AMERICA CORP /DE/ added 3,320,097 shares (+72.4%) to their portfolio in Q4 2025, for an estimated $144,723,028
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
EXC Analyst Ratings
Wall Street analysts have issued reports on $EXC in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 01/27/2026
- Barclays issued a "Overweight" rating on 01/22/2026
- Wells Fargo issued a "Overweight" rating on 01/20/2026
To track analyst ratings and price targets for EXC, check out Quiver Quantitative's $EXC forecast page.
EXC Price Targets
Multiple analysts have issued price targets for $EXC recently. We have seen 12 analysts offer price targets for $EXC in the last 6 months, with a median target of $52.5.
Here are some recent targets:
- James Thalacker from BMO Capital set a target price of $52.0 on 04/02/2026
- Ryan Levine from Citigroup set a target price of $58.0 on 03/26/2026
- Jeremy Tonet from JP Morgan set a target price of $53.0 on 03/12/2026
- Nicholas Amicucci from Evercore ISI Group set a target price of $58.0 on 03/05/2026
- Sophie Karp from Keybanc set a target price of $44.0 on 03/04/2026
- Daniel Ford from UBS set a target price of $51.0 on 02/20/2026
- Paul Fremont from Mizuho set a target price of $51.0 on 02/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
